$TWST This new video about "Oncology in Practice" focuses on how Twist and OncoDNA are collaborating to bring highly advanced liquid biopsies directly into local hospital laboratories:
youtu.be/ey3idb3LT4Y
La société carolo OncoDNA va commercialiser un test sanguin de détection précoce du cancer, qui a été développé par la KU Leuven. Une première du genre en Europe. lecho.be/entreprises/tech-sc…
We’re pleased to share that @OncoDNA will be exhibiting at The Festival of Genomics and Biodata in London next month! If you want to explore the exhibition floor, register for your ticket now: hubs.la/Q02Z19pL0#FOG2025
Exhibitor alert! @OncoDNA will be joining our vibrant exhibition floor at The Festival of Genomics and Biodata in London! Grab your ticket now and join us in January: hubs.la/Q02TFN_c0#FOG2025
In #NextGenSequencing news, MGI Tech takes more steps to become the Illumina $ILMN replacement in China (and sphere of influence), signing a collaboration with OncoDNA for Comprehensive Genomic Profiling (CGP), using their DNBSEQ NGS technology.
We are excited to announce the collaboration with OncoDNA to bring the OncoDEEP® Kit workflow to MGI sequencers, enabling labs to implement Comprehensive Genomic Profiling with efficiency and precision!
Read more: en.mgi-tech.com/news/512/#PrecisionMedicine#NGS#CGP
28 mai 2024 19:24
La société carolo OncoRNA, une spin-out de OncoDNA, va développer des vaccins thérapeutiques contre le cancer basés sur l'ARN messager. Elle pourra recevoir jusqu'à 30 millions de subsides de la Région.
"OncoDNA (Gosselies) lance un projet à €30Mio contre le cancer" => comprendre OncoDNA va recevoir un subside de €30 Mio de la Wallonie pour financer un projet extrêment risqué qui a très peu de chances d'aboutir seul. #walgov#wishfulthinkinglecho.be/entreprises/pharma-…
👉Изследването OncoDEEP® е част от цялостната платформа OncoKDMTM, която позволява на потребителите да проучат параметрите на контрол и качество при всяка анализирана проба. Приложението на OncoKDMTM осигурява достъп до база данни, включваща над 4 500 000 генетични варианта, 1 150 лекарствени продукта и 7 000 клинични проучвания.
Удобните за потребителите софтуерни инструменти улесняват генерирането на клинично значими резултати за пациента.
Лабораторията по молекулярна патология към Gustave Roussy коментира радостта на екипа от прилагането на изследването OncoDEEP® и използването на платформата OncoKDMTM като най - добро решение за молекулярна характеристика за анализ на туморни кохорти.
✅Не забравяйте, че можете да се възползвате от -10% от всички изследвания на OncoDNA в портфолиото на NM Genomix!
Вижте повече за изследването OncoDEEP®: nmgenomix.com/oncodeep/
Sur le forum boursorama il y a une théorie intéressante sur la véracité des chiffres et sur l'OPA qui peut en découler.
En tous cas OncoDNA n'a sans doute pas levé 6.5M pour rien...
Ils peuvent racheter le restant de la boîte et mettre la main sur la tréso
La société carolo OncoDNA, spécialisée dans les tests de profilage pour le traitement du cancer, lève 6,5 millions et vise la rentabilité à court terme. Le président Jean Stephenne cède sa place. @Sambrinvest@WEntreprendre_@BioWin_asbl @essenscia_FR lecho.be/entreprises/pharma-…
✨Qui de mieux que les participants pour parler de la 8ème édition de #MEET2WIN, Convention Partnering en Oncologie ?
🔎 Découvrez l'interview Fast & Curious de Michäel Herman, Global Molecular Specialist Liaison à @OncoDNA
📅Save the date MEET2WIN 2024 : 16 & 17 mai 2024
Our merry team at @OncoDNA is sending their very best wishes for this holiday season🎄and wishing you a sparkling New Year🎉. We are grateful for the trust you have placed in us, and we hope to keep on bringing you closer to your dreams in the year to come✨.